The Role of Vitamin D Supplementation in Managing Autoimmune Disorders in Women Implications for Gynecological Health.

Main Article Content

Dr Hemasa Gul, Dr Nabila Khan, Dr Reema Gul, Dr Huma Gul, Dr Fatima, Prof Dr Muhammad Hussain, Dr Saad Ali, Dr Irsa Hidayat, Dr Ammad Ali, Dr Farhat Rehman

Abstract

Background: The function of vitamin D in the human body was found to be critical for immune regulation, and the deficiency in vitamin D has been seen to cause several autoimmune diseases; most gynecological conditions often affect women. Thus, growing evidence shows that vitamin D might be effective for immunological disorders including SLE, RA and thyroid autoimmune diseases. This paper focuses on the impact of vitamin D administration on inflammation in autoimmune disease female patients to better understand better patient outcomes as well as gynecological implications.


Objectives: To assess the effect of vitamin D on disease activity in female autoimmune disease patients and to establish possible advantages of vitamin D in managing gynecologic health extenuated autoimmune complications.


Study design: A Cross sectional study.


Duration and place of study. The department of  Obs & Gynae and Surgical Unit from jan 2023 to Dec 2023


Methods: 150 women of childrearing age with a doctor’s diagnosis of an autoimmune disease: SLE, RA, or autoimmune thyroid disease. Participants were divided into two groups: One group of patients was given 1000 IU of vitamin D daily while the others were not. DAS at 28 and vitamin D at baseline and after One Year  of intervention were compared. Scoring systems were used according to SLEDAI for SLE and DAS28 for RA; results were analyzed by SPSS version 24.0.


Results: 150 women consumers of vitamin D had lower disease activity scores than the control group. The mean SLEDAI score reduction for SLE was 2.3 ± 0.7 in the supplemented group, and 1.0 ± 0.6 in the controls (p=0.03). DAS28 was reduced in RA patients at the end of supplementation 1.5 ± 0.3 in the supplemented group compared with controls 0.7 ± 0.4 (p = 0.02). The level of standard deviation for disease activity was relatively low, 0.6 in the supplemented group and 0.8 in the control group, indicating that vitamin D helps to reduce the variability of the disease.


Conclusion: vitamin D supplementation modulated autoimmune disease activity: implications for gynecologic disorders. It is important to learn how to maintain normal serum vitamin D concentrations in order to better treat autoimmune diseases, enhance the patient’s quality of life and strengthen the immune response. This indicates that predicting and attending to the needs of vitamin D could turn out to be a routine for females with auto-immune diseases.

Article Details

Section
Articles